Merck Foundation, the philanthropic arm of Merck KGaA Germany, together with First Ladies of Africa and Asia, who are also ...

Phenom unveiled its 2025 Talent Experience awards winners — celebrating the extraordinary achievements by organizations, ...

Merck’s lupus drug enpatoran has failed to meet the primary endpoint in a subgroup of patients, but the drug's development is ...

DelveInsight's "BAVENCIO Market Size, Forecast, and Market Insight Report" highlights the details around BAVENCIO, a human ...

All the latest breaking news on United States. Browse ibtimes archives of photos, videos and articles on United States.

SpringWorks Therapeutics is working on new potential indications for its IP portfolio while running additional trials. See ...

Machine learning is driving efforts to classify MS into distinct subtypes that may predict disease course, but two experts debate whether this will advance patient care.

With the rising adoption of checkpoint inhibitors and combination therapies, BAVENCIO's market growth is driven by expanding indications and strategic partnerships. However, competition from ...

Vaccinex, Inc. (OTC: VCNX) ("Vaccinex" or the "Company"), a clinical-stage biotechnology company pioneering a differentiated approach to treating neurodegenerative ...

Market traders are also anticipating at least two more rate cuts by the end of 2025 to support the Canadian economy in the face of slower global growth and trade uncertainties. In the U.S., stocks ...

Development strategies designed to reduce the unknowns so that cell and gene therapy innovators can develop robust processes ...